442 related articles for article (PubMed ID: 26179950)
41. The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer.
Markar SR; Bodnar A; Rosales J; Song G; Low DE
Ann Surg Oncol; 2013 Nov; 20(12):3935-41. PubMed ID: 23892525
[TBL] [Abstract][Full Text] [Related]
42. Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.
Lu RD; Wei ZD; Liu YX; Tian D; Zhang HL; Shang QX; Hu WP; Yang L; Yang YS; Chen LQ
BMC Cancer; 2024 Feb; 24(1):177. PubMed ID: 38317075
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of subcarinal lymph node metastasis in patients with esophageal squamous cell carcinoma.
Feng JF; Zhao Q; Chen QX
Asian Pac J Cancer Prev; 2013; 14(5):3183-6. PubMed ID: 23803101
[TBL] [Abstract][Full Text] [Related]
44. Clinical Outcome of Esophagectomy in Elderly Patients With and Without Neoadjuvant Therapy for Thoracic Esophageal Cancer.
Miyata H; Yamasaki M; Makino T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S794-801. PubMed ID: 26224407
[TBL] [Abstract][Full Text] [Related]
45. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
46. Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three-field dissection in selected patients with thoracic esophageal squamous cell carcinoma.
Li H; Yang S; Zhang Y; Xiang J; Chen H
J Surg Oncol; 2012 May; 105(6):548-52. PubMed ID: 22105736
[TBL] [Abstract][Full Text] [Related]
47. Intranodal cytokeratin particles is a predictive marker of efficacy for neoadjuvant therapies in patients with squamous cell carcinoma of the esophagus.
Lee T; Tanaka H; Ohira M; Kubo N; Sakurai K; Toyokawa T; Muguruma K; Yamashitaz Y; Maeda K; Hirakawa K
Hepatogastroenterology; 2014; 61(133):1235-40. PubMed ID: 25436289
[TBL] [Abstract][Full Text] [Related]
48. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
49. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma.
Baba Y; Watanabe M; Shigaki H; Iwagami S; Ishimoto T; Iwatsuki M; Baba H
Surgery; 2013 Feb; 153(2):234-41. PubMed ID: 22980434
[TBL] [Abstract][Full Text] [Related]
50. The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal Cancer.
Kano K; Aoyama T; Yoshikawa T; Maezawa Y; Nakajima T; Hayashi T; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Cho H; Ogata T
Ann Surg Oncol; 2018 Jul; 25(7):2034-2043. PubMed ID: 29748890
[TBL] [Abstract][Full Text] [Related]
51. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
[TBL] [Abstract][Full Text] [Related]
52. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Prenzel KL; König A; Schneider PM; Schnickmann C; Baldus SE; Schröder W; Bollschweiler E; Dienes HP; Mueller RP; Izbicki JR; Hölscher AH
Ann Surg Oncol; 2007 Feb; 14(2):954-9. PubMed ID: 17103071
[TBL] [Abstract][Full Text] [Related]
53. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
[TBL] [Abstract][Full Text] [Related]
54. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status.
Zheng YZ; Zhao W; Hu Y; Ding-Lin XX; Wen J; Yang H; Liu QW; Luo KJ; Huang QY; Chen JY; Fu JH
World J Gastroenterol; 2015 Jul; 21(28):8644-52. PubMed ID: 26229406
[TBL] [Abstract][Full Text] [Related]
55. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
[TBL] [Abstract][Full Text] [Related]
56. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
[TBL] [Abstract][Full Text] [Related]
57. Number of Resected Lymph Nodes and Survival of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.
Guo JC; Lin CC; Huang TC; Huang PM; Kuo HY; Chang CH; Wang CC; Cheng JC; Yeh KH; Hsu CH; Lee JM
Anticancer Res; 2018 Mar; 38(3):1569-1577. PubMed ID: 29491087
[TBL] [Abstract][Full Text] [Related]
58. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
[TBL] [Abstract][Full Text] [Related]
59. Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Kim J; Wong JY; Chen YJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S580-7. PubMed ID: 25956577
[TBL] [Abstract][Full Text] [Related]
60. [Impact of number of dissected lymph nodes on survival in patients with thoracic esophageal squamous cell carcinoma after radical resection].
Wang YX; Wang LL; Yang Q; He M; Qi Z; Qiao XY; Zhu SC
Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):150-5. PubMed ID: 26899337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
